effect of consumption of cake prepared with acorn flour in type 2 diabetes

Evaluation of the effects of cake prepared with acorn flour on glycemic markers, lipid profile, oxidative stress and anthropometric indicators in type 2 diabetes patients: a double-blind clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191009045042N1

Enrollment

Registered

2020-02-16

Start date

2019-12-22

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: One cake made with acorn flour daily for 60 days. Intervention 2: Control group: One cake made with wheat flour without bran daily for 60 days.

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes (doctor's diagnosis)

Exclusion criteria

Exclusion criteria: Using insulin Following a specific diet (vegetarianism, weight loss, etc.) Pregnancy or lactation

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar. Timepoint: Before and after intervention. Method of measurement: Obtain 5 cc of blood after 12 hours of fasting.;Insulin. Timepoint: Before and after intervention. Method of measurement: Obtain 5 cc of blood after 12 hours of fasting.;Hemoglobin A1c. Timepoint: Before and after intervention. Method of measurement: Obtain 5 cc of blood after 12 hours of fasting.;Insulin resistance. Timepoint: Before and after intervention. Method of measurement: With HOMA-IR index and formula.	—

Measure

Time frame

Fasting blood sugar. Timepoint: Before and after intervention. Method of measurement: Obtain 5 cc of blood after 12 hours of fasting.;Insulin. Timepoint: Before and after intervention. Method of measurement: Obtain 5 cc of blood after 12 hours of fasting.;Hemoglobin A1c. Timepoint: Before and after intervention. Method of measurement: Obtain 5 cc of blood after 12 hours of fasting.;Insulin resistance. Timepoint: Before and after intervention. Method of measurement: With HOMA-IR index and formula.

—

Secondary

Measure	Time frame
Triglyceride. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;Total cholesterol. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;HDL cholesterol. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;LDL cholesterol. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;Malone dialdehyde. Timepoint: Before and after intervention. Method of measurement: Biochemical method of thiobarbituric acid.;Total antioxidant capacity. Timepoint: Before and after intervention. Method of measurement: Colorimetric method.;Anthropometric measurements. Timepoint: Before and after intervention. Method of measurement: scale, meter.	—

Measure

Time frame

Triglyceride. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;Total cholesterol. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;HDL cholesterol. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;LDL cholesterol. Timepoint: Before and after intervention. Method of measurement: Enzymatic colorimetric method.;Malone dialdehyde. Timepoint: Before and after intervention. Method of measurement: Biochemical method of thiobarbituric acid.;Total antioxidant capacity. Timepoint: Before and after intervention. Method of measurement: Colorimetric method.;Anthropometric measurements. Timepoint: Before and after intervention. Method of measurement: scale, meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Sasani

Shiraz University of Medical Sciences

n_sasani@sums.ac.ir+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026